Publications found:
705
Sort by:
Global Liver Cancer Therapeutics Market - 2025 -2033
US$ 4,350.00
Liver Cancer Therapeutics Market: Industry Outlook The liver cancer therapeutics market reached US$ 2.92billionin 2023,with a rise of US$3.36billion in 2024, and is expected to reach US$ 13.16billionb...
October 2025
180 pages
Global Lung Cancer Therapeutics Market - 2025 -2033
US$ 4,350.00
Global Lung Cancer Therapeutics Market: Industry Outlook The global lung cancer therapeutics market reached US$ 24.00 Billion in 2023, with a rise of US$ 25.92 Billion in 2024 and is expected to reach...
October 2025
180 pages
Global Oncolytic Viral Therapy Market - 2025 -2033
US$ 4,350.00
Oncolytic Viral Therapy Market Size Oncolytic Viral Therapy Market Size reached US$ 24.48 Million in 2024 and is expected to reach US$ 164.51 Million by 2033, growing at a CAGR of 23.8% during the for...
October 2025
180 pages
Global PD-L1 Testing and Therapeutics Market - 2025 -2033
US$ 4,350.00
Global PD-L1 Testing and Therapeutics Market: Industry Outlook The global PD-L1 Testing and Therapeutics market reached US$ 52.05 billion in 2023, with a rise of US$ 57.82 billion in 2024, and is expe...
October 2025
180 pages
Global Thymus Cancer Market - 2025 -2033
US$ 4,350.00
Thymus Cancer Market Size In 2023, the global thymus cancer was valued at US$ 4.82 Billion. The global thymus cancer market size reached US$ 5.03 Billion in 2024 and is expected to reach US$ 7.80 Bill...
October 2025
180 pages
Global Triple Negative Breast Cancer Market - 2025 -2033
US$ 4,350.00
Triple Negative Breast Cancer Treatment Market Size and Trends The global triple negative breast cancer Treatment Market reached US$ 0.95billion in 2023, with a rise to US$ 1.00billion in 2024, and is...
October 2025
180 pages
India Prostate Cancer Market - 2025 -2033
US$ 3,175.00
India Prostate Cancer Treatment Market: Industry Outlook The India Prostate Cancer Treatment market reached US$ 12,146.00 Million in 2023, with a rise of US$ 13,220.00 Million in 2024 and is expected...
October 2025
180 pages
Global Fluorouracil Tablets Market Growth 2025-2031
US$ 3,660.00
The global Fluorouracil Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for Fluor...
September 2025
102 pages
Global EGFR Inhibitor Market Growth 2025-2031
US$ 3,660.00
The global EGFR Inhibitor market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for EGFR Inhibi...
September 2025
123 pages
Global Fulvestrant Injection Market Growth 2025-2031
US$ 3,660.00
The global Fulvestrant Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for Fulv...
September 2025
106 pages
Global Gefitinib Tablets Market Growth 2025-2031
US$ 3,660.00
The global Gefitinib Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for Gefitini...
September 2025
113 pages
Global Carmustine Injection Market Growth 2025-2031
US$ 3,660.00
The global Carmustine Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for Carmu...
September 2025
88 pages
Global CTLA-4 Inhibitors Market Growth 2025-2031
US$ 3,660.00
The global CTLA-4 Inhibitors market size is predicted to grow from US$ 1297 million in 2025 to US$ 2319 million in 2031; it is expected to grow at a CAGR of 10.2% from 2025 to 2031. CTLA-4, cytotoxic...
September 2025
93 pages
Liposomal Doxorubicin Market Size, Share & Trends Analysis Report By Product (Doxil/Caelyx, Lipodox, Myocet), By Application (Multiple Myeloma, Ovarian Cancer, Breast Cancer, AIDS-related Kaposi’s Sarcoma), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
Liposomal Doxorubicin Market The global liposomal doxorubicin market size was estimated at USD 1.31 billion in 2024 and is projected to reach USD 2.38 billion by 2033, growing at a CAGR of 7.04% from...
September 2025
125 pages
NUT Midline Carcinoma Treatment Market Size, Share & Trends Analysis Report By Treatment (Chemotherapy, Targeted Therapy), By Route Of Administration (Oral, IV), By End Use, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
NUT Midline Carcinoma Treatment Market The global NUT midline carcinoma treatment market size was estimated at USD 21.44 billion in 2024 and is projected to reach USD 69.53 billion by 2033, growing at...
September 2025
120 pages
Oncology Drugs Market Forecasts to 2032 – Global Analysis By Drug Class (Cytotoxic Drugs, Targeted Therapy Drugs, Hormonal Therapy Drugs, Immunotherapy Drugs, and Other Drug Classes), Therapy Type, Cancer Type, Dosage Form, Distribution Channel, and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Oncology Drugs Market is accounted for $258.98 billion in 2025 and is expected to reach $620.70 billion by 2032 growing at a CAGR of 13.3% during the forecast...
September 2025
200 pages
AI Tumor Evolution Maps Market Forecasts to 2032 – Global Analysis By Cancer Type (Brain Cancer, Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Pancreatic Cancer, Hematologic Malignancies, Rare & Pediatric Cancers and Other Cancer Types), Technology, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global AI Tumor Evolution Maps Market is accounted for $196.03 million in 2025 and is expected to reach $1390.77 million by 2032 growing at a CAGR of 32.3% during the...
September 2025
200 pages
Radioligand Therapy (RLT) Market by Product (Lutetium-177 Vipivotide Tetraxetan, (Lu-177)- PNT2002, Radium-223 dichloride), Target (PSMA, SSTR, Bone Metastases), Indication (Prostate Cancer, Neuroendocrine Tumors (NETS), SCLC) - Global Forecast to 2035
US$ 4,950.00
The global radioligand therapy market is projected to reach USD 10.91 billion by 2035 from an estimated USD 3.15 billion in 2025, at a CAGR of 13.2% during the forecast period. The growth of the radio...
September 2025
313 pages
Targeted Alpha Therapies for Cancer Treatment: Global Market
US$ 2,950.00
Report The report provides an overview of the global market for targeted alpha therapies (TAT) for cancer and analyzes market trends. It includes global revenue ($ million) for the base year data 2024...
September 2025
81 pages
NUT Midline Carcinoma Treatment Market Forecasts to 2032 – Global Analysis By Treatment Type (Chemotherapy, Targeted Therapy, Radiation Therapy, Immunotherapy, and Surgery), Route of Administration, Technology, Drug Class, Distribution Channel, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global NUT Midline Carcinoma Treatment Market is accounted for $24.99 billion in 2025 and is expected to reach $73.25 billion by 2032 growing at a CAGR of 16.6% durin...
September 2025
200 pages
Skin Cancer Treatment Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Melanoma and Non-Melanoma); Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, Radiation Therapy, and Others); End User (Hospitals, Dermatology Clinics, Diagnostic and Cancer Care Centers, and Others); and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
US$ 4,450.00
The skin cancer treatment market size is projected to rise from US$11.79 billion in 2024 to reach US$19.53 billion by 2031. The market is expected to register a CAGR of 7.57% from 2025 to 2031. Major...
September 2025
241 pages
Global Cancer/Tumor Profiling Market Size study & Forecast, by Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, and Other Cancer), Biomarker Type (Genomic Biomarker and Protein Biomarker), Technology, Technique, Application and Regional Forecasts 2025-2035
US$ 3,750.00
... – 2019 to 2026 Target Audience of the Global Cancer/Tumor Profiling Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises Venture capitalists Value ...
September 2025
285 pages
Acute Myeloid Leukemia Therapeutics Market Report by Treatment Type (Cytarabine, Anthracycline Drugs, Alkylating Agents, Anti-Metabolites, Tyrosine Kinase Inhibitors, and Others), Drug Type (Small Molecule Drugs, Biopharmaceuticals), Route of Administration (Oral, Injectables), and Region 2025-2033
US$ 3,999.00
The global acute myeloid leukemia therapeutics market size reached USD 1,343.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 3,461.4 Million by 2033, exhibiting a growt...
September 2025
144 pages
Hematologic Malignancies Market Report by Type (Leukemia, Lymphoma, Multiple Myeloma, and Others), Therapy (Chemotherapy, Radiotherapy, Immunotherapy, Stem Cell Transplantation, and Others), End User (Hospitals, Diagnostics Centers, Research Centers, and Others), and Region 2025-2033
US$ 3,999.00
The global hematologic malignancies market size reached USD 65.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 129.5 Billion by 2033, exhibiting a growth rate (CAGR) of...
September 2025
143 pages
Lymphoma Treatment Market Report by Type (Hodgkin Lymphoma, Non-Hodgkin Lymphoma), Test Type (Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy, Biologic Therapy, and Others), Drug (Adcetris, Rituxan, Opdivo, Imbruvica, Keytruda, Revlimid, and Others), and Region 2025-2033
US$ 3,999.00
The global lymphoma treatment market size reached USD 14.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 27.4 Billion by 2033, exhibiting a growth rate (CAGR) of 7.13%...
September 2025
139 pages
U.S. Liver Cancer Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Laboratory Tests, Imaging, Endoscopy, Biopsy), By End-use (Hospitals & Diagnostic Laboratories, Pharmaceutical & CRO Laboratories), And Segment Forecasts, 2025 - 2033
US$ 5,950.00
U.S. Liver Cancer Diagnostics Market Trends The U.S. liver cancer diagnostics market size was estimated at USD 3.14 billion in 2024 and is projected to reach USD 4.44 billion by 2033, growing at a CAG...
August 2025
150 pages
Middle East Liver Cancer Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Laboratory Tests, Imaging, Endoscopy, Biopsy), By End-Use, By Country, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
Market Size & Trends The Middle East liver cancer diagnostics market size was estimated at USD 268.10 million in 2024 and is projected to reach USD 466.42 million by 2033, growing at a CAGR of 6.35% f...
August 2025
150 pages
Colorectal Cancer Treatment Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment (Surgery, Chemotherapy, Immunotherapy, Targeted Therapy, and Others), Age Group (Below 49 Years, 50 - 64 Years and Above 65 Years), End Users (Hospitals, Specialty Clinics, Home Care, and Others), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, South and Central America)
US$ 4,450.00
The colorectal cancer treatment market is projected to reach US$24.74 billion by 2031 from US$19.93 billion in 2024. The market is estimated to register a CAGR of 3.2% during 2025-2031. Major factors...
August 2025
241 pages
Cancer Gene Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy (Oncolytic Virotherapy, Gene Induced Immunotherapy, Gene Transfer, and Others), By Indication (Breast Cancer, Ovarian Cancer, Lung Cancer, Liver Cancer, Pancreatic Cancer, Prostate Cancer, and Others), By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, and Others), By Region and Competition, 2020-2030F
US$ 4,500.00
Market Overview Global Cancer Gene Therapy Market was valued at USD 4.52 billion in 2024 and is expected to reach USD 13.58 billion by 2030 with a CAGR of 20.12% during the forecast period. The globa...
August 2025
185 pages
Stomach Cancer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type (Immunotherapy, Targeted Therapy, Chemotherapy, Radiation Therapy, Others), By Cancer Type (Gastric Cancer/Gastroesophageal Junction Cancer, Gastrointestinal Stromal Tumors), By Route of Administration (Oral, Injectables), By Drug Class (PD-1/PD-L1 Inhibitors, HER2 Antagonists, VEGFR2 Antagonists, Others), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
Market Overview Global Stomach Cancer Treatment Market was valued at USD 5.51 billion in 2024 and is expected to reach USD 12.64 billion by 2030 with a CAGR of 14.84% during the forecast period. The...
August 2025
185 pages
Middle East AI In Oncology Market Size, Share & Trends Analysis Report By Component (Software Solutions, Hardware), By Cancer Type (Breast Cancer, Lung Cancer), By Application, By End-use, By Country, And Segment Forecasts, 2025 - 2033
US$ 4,950.00
Middle East AI in Oncology Market Trends The Middle East AI in oncology market size was estimated at USD 111.33 million in 2024 and is projected to grow at a CAGR of 21.94% from 2025 to 2033. The risi...
August 2025
100 pages
U.S. Oncology Based Molecular Diagnostics Market Size, Share & Trends Analysis Report By Type (Breast Cancer, Lung Cancer), By Product (Instruments, Reagents), By Technology (PCR, Sequencing), By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
Market Size & Trends The U.S. oncology based molecular diagnostics market size was estimated at USD 1.49 billion in 2024 and is expected to grow at a CAGR of 5.2% from 2025 to 2033. Key market driving...
August 2025
136 pages
